MedPage Today on MSN
Cassidy Decries Child Vax Changes; First GLP-1 Pill for Obesity; 'Super-Flu' Season?
The first GLP-1 pill for obesity, semaglutide (Wegovy) tablets from drugmaker Novo Nordisk, launched in the U.S. ( CNBC) ...
4don MSN
Hyderabad-Based Pharmaceutical Gets US Nod For Generic ADHD Drug: Why This Matters And What It Means
ADHD is a neurodevelopmental condition that affects both children and adults. It is characterised by symptoms such as ...
4d
Ark Biopharmaceutical Receives China Marketing Authorization for Aizhida for the Treatment of ADHD
Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that China's National Medical Products Administration ...
Verywell Health on MSN
What is ADHD (attention deficit hyperactivity disorder)?
ADHD symptoms often start in childhood and can affect success at school, work, and home. Treatment can improve the lives of ...
German CNS-focused specialist Neuraxpharm Group announced the launches in Europe of Tuzulby (methylphenidate hydrochloride) prolonged-release chewable tablets and Paxneury (guanfacine) ...
The Children's Advocacy Center of Benton County will use its share of a half-million dollars in grants to provide training to ...
Attention-deficit/hyperactivity disorder (ADHD) affects 3%–5% of children and about 2.5% of adults, though prevalence varies ...
China NMPA grants marketing approval for ArkBio’s Azstarys for the treatment of ADHD: Shanghai, China Wednesday, January 7, 2026, 16:00 Hrs [IST] Shanghai Ark Biopharmaceutical ...
New ADHD pipeline leverages TAAP™ and MPAR® technologies to improve safety for patients ~ SAN DIEGO, CALIFORNIA / ACCESS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback